Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.

The global Haemophilus Influenzae Type B Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Haemophilus Influenzae Type B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilus Influenzae Type B Vaccine.

Report Scope

The Haemophilus Influenzae Type B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Haemophilus Influenzae Type B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Haemophilus Influenzae Type B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Haemophilus Influenzae Type B Vaccine Market Report

Report Metric	Details
Report Name	Haemophilus Influenzae Type B Vaccine Market
CAGR	5%
Segment by Type	Liquid Monovalent HIB Liquid Combination HIB Lyophilized Monovalent HIB Lyophilized Combination HIB
Segment by Application	Hospital Research Institutions Pharmaceutical and Biotechnology Companies Academic Institutions Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Merck, Sanofi, GlaxoSmithKline, Takeda Pharmaceuticals Company, Walvax Biotechnology, Lanzhou Institute of Biologica, Immunize BC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Haemophilus Influenzae Type B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Haemophilus Influenzae Type B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Haemophilus Influenzae Type B Vaccine Market report?

Ans: The main players in the Haemophilus Influenzae Type B Vaccine Market are Novartis, Merck, Sanofi, GlaxoSmithKline, Takeda Pharmaceuticals Company, Walvax Biotechnology, Lanzhou Institute of Biologica, Immunize BC

What are the Application segmentation covered in the Haemophilus Influenzae Type B Vaccine Market report?

Ans: The Applications covered in the Haemophilus Influenzae Type B Vaccine Market report are Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other

What are the Type segmentation covered in the Haemophilus Influenzae Type B Vaccine Market report?

Ans: The Types covered in the Haemophilus Influenzae Type B Vaccine Market report are Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB, Lyophilized Combination HIB

1 Haemophilus Influenzae Type B Vaccine Market Overview

1.1 Product Overview and Scope of Haemophilus Influenzae Type B Vaccine

1.2 Haemophilus Influenzae Type B Vaccine Segment by Type

1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Liquid Monovalent HIB

1.2.3 Liquid Combination HIB

1.2.4 Lyophilized Monovalent HIB

1.2.5 Lyophilized Combination HIB

1.3 Haemophilus Influenzae Type B Vaccine Segment by Application

1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Research Institutions

1.3.4 Pharmaceutical and Biotechnology Companies

1.3.5 Academic Institutions

1.3.6 Other

1.4 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts

1.4.1 Global Haemophilus Influenzae Type B Vaccine Revenue 2019-2030

1.4.2 Global Haemophilus Influenzae Type B Vaccine Sales 2019-2030

1.4.3 Global Haemophilus Influenzae Type B Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Haemophilus Influenzae Type B Vaccine Market Competition by Manufacturers

2.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Haemophilus Influenzae Type B Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Haemophilus Influenzae Type B Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Product Type & Application

2.7 Haemophilus Influenzae Type B Vaccine Market Competitive Situation and Trends

2.7.1 Haemophilus Influenzae Type B Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue

2.7.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario by Region

3.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Haemophilus Influenzae Type B Vaccine Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2019-2030

3.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2019-2024

3.2.2 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2025-2030

3.3 Global Haemophilus Influenzae Type B Vaccine Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019-2030

3.3.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019-2024

3.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2025-2030

3.4 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country

3.4.1 North America Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)

3.4.3 North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country

3.5.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)

3.5.3 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country

3.7.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2030)

4.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024)

4.1.2 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030)

4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2030)

4.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024)

4.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030)

4.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)

5.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024)

5.1.2 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030)

5.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)

5.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024)

5.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030)

5.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Corporation Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Merck

6.2.1 Merck Corporation Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Haemophilus Influenzae Type B Vaccine Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Corporation Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Takeda Pharmaceuticals Company

6.5.1 Takeda Pharmaceuticals Company Corporation Information

6.5.2 Takeda Pharmaceuticals Company Description and Business Overview

6.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio

6.5.5 Takeda Pharmaceuticals Company Recent Developments/Updates

6.6 Walvax Biotechnology

6.6.1 Walvax Biotechnology Corporation Information

6.6.2 Walvax Biotechnology Description and Business Overview

6.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio

6.6.5 Walvax Biotechnology Recent Developments/Updates

6.7 Lanzhou Institute of Biologica

6.6.1 Lanzhou Institute of Biologica Corporation Information

6.6.2 Lanzhou Institute of Biologica Description and Business Overview

6.6.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio

6.7.5 Lanzhou Institute of Biologica Recent Developments/Updates

6.8 Immunize BC

6.8.1 Immunize BC Corporation Information

6.8.2 Immunize BC Description and Business Overview

6.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio

6.8.5 Immunize BC Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Haemophilus Influenzae Type B Vaccine Industry Chain Analysis

7.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process

7.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing

7.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels

7.4.2 Haemophilus Influenzae Type B Vaccine Distributors

7.5 Haemophilus Influenzae Type B Vaccine Customers

8 Haemophilus Influenzae Type B Vaccine Market Dynamics

8.1 Haemophilus Influenzae Type B Vaccine Industry Trends

8.2 Haemophilus Influenzae Type B Vaccine Market Drivers

8.3 Haemophilus Influenzae Type B Vaccine Market Challenges

8.4 Haemophilus Influenzae Type B Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceuticals Company

Walvax Biotechnology

Lanzhou Institute of Biologica

Immunize BC

List of Tables

Table 1. Global Haemophilus Influenzae Type B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Haemophilus Influenzae Type B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Haemophilus Influenzae Type B Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)

Table 5. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Haemophilus Influenzae Type B Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Haemophilus Influenzae Type B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Haemophilus Influenzae Type B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2019-2024) & (M Doses)

Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2025-2030) & (M Doses)

Table 20. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)

Table 27. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)

Table 28. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)

Table 32. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)

Table 33. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2019-2024) & (M Doses)

Table 37. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2025-2030) & (M Doses)

Table 38. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)

Table 42. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)

Table 43. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)

Table 47. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)

Table 48. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2019-2024)

Table 51. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Type (2025-2030)

Table 52. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Type (2019-2024)

Table 59. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Type (2025-2030)

Table 60. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2019-2024)

Table 61. Global Haemophilus Influenzae Type B Vaccine Sales (M Doses) by Application (2025-2030)

Table 62. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Application (2019-2024)

Table 69. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Application (2025-2030)

Table 70. Novartis Corporation Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Novartis Haemophilus Influenzae Type B Vaccine Product

Table 74. Novartis Recent Developments/Updates

Table 75. Merck Corporation Information

Table 76. Merck Description and Business Overview

Table 77. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. Merck Haemophilus Influenzae Type B Vaccine Product

Table 79. Merck Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Sanofi Haemophilus Influenzae Type B Vaccine Product

Table 84. Sanofi Recent Developments/Updates

Table 85. GlaxoSmithKline Corporation Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Takeda Pharmaceuticals Company Corporation Information

Table 91. Takeda Pharmaceuticals Company Description and Business Overview

Table 92. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product

Table 94. Takeda Pharmaceuticals Company Recent Developments/Updates

Table 95. Walvax Biotechnology Corporation Information

Table 96. Walvax Biotechnology Description and Business Overview

Table 97. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product

Table 99. Walvax Biotechnology Recent Developments/Updates

Table 100. Lanzhou Institute of Biologica Corporation Information

Table 101. Lanzhou Institute of Biologica Description and Business Overview

Table 102. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product

Table 104. Lanzhou Institute of Biologica Recent Developments/Updates

Table 105. Immunize BC Corporation Information

Table 106. Immunize BC Description and Business Overview

Table 107. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Immunize BC Haemophilus Influenzae Type B Vaccine Product

Table 109. Immunize BC Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Haemophilus Influenzae Type B Vaccine Distributors List

Table 113. Haemophilus Influenzae Type B Vaccine Customers List

Table 114. Haemophilus Influenzae Type B Vaccine Market Trends

Table 115. Haemophilus Influenzae Type B Vaccine Market Drivers

Table 116. Haemophilus Influenzae Type B Vaccine Market Challenges

Table 117. Haemophilus Influenzae Type B Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Haemophilus Influenzae Type B Vaccine

Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2023 & 2030

Figure 4. Liquid Monovalent HIB Product Picture

Figure 5. Liquid Combination HIB Product Picture

Figure 6. Lyophilized Monovalent HIB Product Picture

Figure 7. Lyophilized Combination HIB Product Picture

Figure 8. Global Haemophilus Influenzae Type B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Research Institutions

Figure 12. Pharmaceutical and Biotechnology Companies

Figure 13. Academic Institutions

Figure 14. Other

Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Haemophilus Influenzae Type B Vaccine Market Size (2019-2030) & (US$ Million)

Figure 17. Global Haemophilus Influenzae Type B Vaccine Sales (2019-2030) & (M Doses)

Figure 18. Global Haemophilus Influenzae Type B Vaccine Average Price (USD/Dose) & (2019-2030)

Figure 19. Haemophilus Influenzae Type B Vaccine Report Years Considered

Figure 20. Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers in 2023

Figure 21. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Haemophilus Influenzae Type B Vaccine Players: Market Share by Revenue in 2023

Figure 23. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Haemophilus Influenzae Type B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2019-2030)

Figure 26. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2019-2030)

Figure 27. U.S. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2019-2030)

Figure 30. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2019-2030)

Figure 31. Germany Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2019-2030)

Figure 38. China Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2019-2030)

Figure 49. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. U.A.E Haemophilus Influenzae Type B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Haemophilus Influenzae Type B Vaccine by Type (2019-2030)

Figure 59. Global Revenue Market Share of Haemophilus Influenzae Type B Vaccine by Type (2019-2030)

Figure 60. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Type (2019-2030)

Figure 61. Global Sales Market Share of Haemophilus Influenzae Type B Vaccine by Application (2019-2030)

Figure 62. Global Revenue Market Share of Haemophilus Influenzae Type B Vaccine by Application (2019-2030)

Figure 63. Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose) by Application (2019-2030)

Figure 64. Haemophilus Influenzae Type B Vaccine Value Chain

Figure 65. Haemophilus Influenzae Type B Vaccine Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions